Bax∆2 is a pro-apoptotic protein originally discovered in colon cancer patients with high microsatellite instability. Unlike most pro-apoptotic Bax family members, Bax∆2 mediates cell death through a non-mitochondrial caspase 8-dependent pathway. In the scope of analyzing the distribution of Bax∆2 expression in human tissues, we examined a panel of human brain samples. Here, we report 4 cerebellar cases in which the subjects had no neurological disorder or disease documented. We found Bax∆2 positive cells scattered in all areas of the cerebellum, but most strikingly concentrated in Purkinje cell bodies and dendrites. Two out the four subjects tested had strong Bax∆2positive staining in nearly all Purkinje cells; one was mainly negative; and one had various levels of positive staining within the same sample. Further genetic analysis of the Purkinje cell layer, collected by microdissection from two subjects, showed that the samples contained G7 and G9 Bax microsatellite mutations. Both subjects were young and had no diseases reported at the time of death. As the distribution of Bax∆2 is consistent with that known for Baxα, but in a less ubiquitous manner, these results may imply a potential function of Bax∆2 in Purkinje cells.
Introduction
The cerebellum is the area of the brain responsible for the modification of motor commands and is involved in balance, posture, voluntary movements, motor learning and more (Koziol et al. 2014; Bernard and Seidler 2014) . The cerebellar cortex is composed of three layers, the granular layer, the Purkinje cell layer, and the molecular layer. The dendritic trees from Purkinje cells extend into the molecular layer (Casoni et al. 2017) . Recent studies showed that Purkinje cells play a role in information storage for learned response sequences in coordination of motor behaviors (Jirenhed et al. 2017 ). It also has been shown that Purkinje cells may be involved in the pathophysiology of schizophrenia (Picard et al. 2007; Mothersill et al. 2016) .
Bax is a pro-apoptotic Bcl-2 family member, that is ubiquitously distributed throughout all human tissues (Krajewski et al. 1994; Penault-Llorca et al. 1998 ). Bax plays a critical role in development and in tissue homeostasis, and its dysregulation can lead to many diseases. Due its involvement in the development and progression of neurodegenerative diseases and ischemic insults, expression and distribution of Bax in the brain has been widely studied (Hara et al. 1996; Fan et al. 2001; Vogel 2002; Dorszewska et al. 2004; Jung et al. 2008; Didonna et al. 2012; Garcia et al. 2013) . Bax is known to have several functional isoforms, but only the distribution of the canonical isoform, Baxα, has been fully studied. Baxα is present in all the different areas of the brain, mainly in neuronal bodies, with very low to no presence in glial cells (Hara et al. 1996; Vogel 2002; Didonna et al. 2012) . Cerebellar Purkinje cells and hippocampal neurons have the highest levels of Baxα (Hara et al. 1996; Vogel 2002; Casoni et al. 2017) , which is believed to be the reason why these cells are so vulnerable to ischemic insults (Krajewski et al. 1995) . Apart from its apoptotic role, other physiological functions of Baxα in the brain are unknown.
Bax∆2 is a unique isoform of the Bax subfamily originally discovered in colorectal cancer patients with high microsatellite instability (MSI-H) (Haferkamp et al. 2012; Zhang et al. 2015) . It is generally believed that generation of Bax∆2 requires a microsatellite frameshift mutation in combination with an alternative splicing event that restores the reading frame. Like Baxα, Bax∆2 is pro-apoptotic and has similar characteristics, such as binding with Bcl-2; however, Bax∆2 does not target mitochondria, and instead activates a caspase 8-dependent death pathway (Haferkamp et al. 2012; Zhang et al. 2014; Mañas et al. 2017) . In the process of analyzing the expression and distribution of Bax∆2 throughout the human body, we examined several tissue sections of human brain. Here, we report the expression and distribution of Bax∆2 in the cerebellum of four young and healthy human subjects.
Materials and methods

Materials
All tissue sections and tissue microarray slides were commercially obtained from Biomax. All samples were de-identified and assigned with codes. Antibody against Bax∆2 was generated previously (Haferkamp et al. 2012) .
Immunohistochemistry and tissue analysis
Tissue slides were de-waxed using xylene and rehydrated using graded ethanol solutions. Endogenous peroxidase activity was blocked using 0.3% hydrogen peroxide.
Slides were incubated in sodium citrate buffer (0.01 M, pH 6.0) at 95ºC for epitope retrieval. After blocking with 5% BSA, CoverWell® incubation humidity chambers were used to incubate the slides with anti-Bax∆2 antibody (1:100 in blocking buffer) at 4ºC overnight and then with Biotin-conjugated Goat anti-mouse secondary antibody (1:200 in PBS) at room temperature for 2 hours. Vectrastain® ABC Kit (Vector Laboratories) and ImmPACT™ DAB Peroxidase Substrate Kit (Vector Laboratories) were used for visualization, and Hematoxolin QS (Vector Laboratories) was used for nuclear staining. The stained tissue sections of cerebellum from Subjects 1 and 3 were uncovered using xylene and dehydrated with graded ethanol solutions. The Purkinje cells layer was microdissected under a microscope using a sterile needle. The tissue was collected and lysed with Proteinase K. DNA was then isolated using AMPure XP magnetic beads (Beckman Coulter). Sanger sequencing was performed at the DNA Sequencing & Genotyping Facility at the University of Chicago Comprehensive Cancer Center.
Results and Discussion
The monomeric form of Baxα is ubiquitously distributed throughout different human tissues, including the brain (Hara et al. 1996) . However, distribution of other Bax isoforms is unknown. In the process of screening the tissue distribution of Bax∆2, we found 4 interesting cases involving brain cerebellar tissues. The patient information about these 4 subjects was summarized in Figure 1A . There were two males and two females, all between the ages of 15 and 35. All subjects were healthy at the time of death and had no tumors or neuronal diseases reported. All tissues were immunohistochemically stained with an anti-Bax∆2 antibody, which has been shown previously to be very specific for Bax∆2 and has no cross-staining with parental Baxα.
We detected significant amounts of Bax∆2-positive cells in three out of the four subjects. Figure 1B Further analysis of the positive samples showed that most Bax∆2-positive staining was detected in the Purkinje cell bodies ( Fig. 2A) , as well as in the dendrites extending into the molecular layer (Fig. 2D, 2E and 2F) . In contrast with the strong positive-stained Purkinje cells, we also observed some weaker positive cells scattered throughout the granular layer ( Fig. 2B ) and the molecular layer (Fig. 2C) . The nature of these cells remains to be determined; however, morphologically, they appeared to be granule cells and Golgi cells in the granular layer, and basket cells (large nuclei and close to the Purkinje cell layer) and stellate cells (smaller nuclei and body size) in the molecular layer. Overall, Bax∆2 seemed evenly distributed in the cerebellum at low levels, with significantly higher Bax∆2-positive staining in the Purkinje cells. These results are consistent with published data for the distribution of Baxα, which also presents higher levels in Purkinje cells. However, the amount and distribution of BaxΔ2positive cells, outside of the Purkinje cell layer, was lower and less ubiquitous than for Baxα (Hara et al. 1996) .
As shown in
BaxΔ2 was previously detected in MSI-H tumors which involve mutations in the
Bax microsatellite (Haferkamp et al. 2012) . As none of these subjects were reported to have any tumors or neurological conditions, we wondered whether they could have a Bax microsatellite mutation. Due to limited sample size and variation of sample quality, we were only able to genetically analyze two of the four subjects. The tissue slides were first immunohistochemically stained with anti-Bax∆2 antibody, then the Purkinje cell layer was carefully harvested through microdissection under a microscope, as shown in Figure 3A , and finally genomic DNA was isolated for sequence analysis. A 200 basepair segment of the Bax gene containing the microsatellite region, was amplified by PCR and subjected to Sanger sequence analysis. As shown in Fig 3B, in comparison with the wild type Bax microsatellite, which contains a stretch of eight guanines (G8), the sample from Subject 1 contains a G9 mutation and the sample from Subject 3 contains a G7 mutation.
It is generally believed that expression of Bax∆2 requires a Bax microsatellite G7 mutation and an alternative splicing event, which salvages the frameshift caused by the guanine deletion (Haferkamp et al. 2012 ). The result from Subject 3 seemed consistent with the Bax∆2-positive staining, as the G7 mutation was detected. However, a G9 mutation was detected for Subject 1, who also had a strong Bax∆2 staining in the area dissected, similar to that in Subject 3. This cannot be explained by the general rule for Bax∆2 expression. Although we have previously shown that the G9 mutation can generate another Bax∆2 sub-isoform, Bax∆2(G9), which has a similar behavior as Bax∆2 (Haferkamp et al. 2013) , the antibody used here is specific for BaxΔ2 and does not cross react with Bax∆2(G9). One possibility is that the area collected by microdissection also contained a significant amount of unstained cells with predominant G9 genotype. Another possibility is that the G8-to-G7 deletion could occur at the transcriptional level by transcriptional slippage, or at the translational level by ribosomal frameshift (Ketteler 2012; Atkins et al. 2016) . Both transcriptional slippage and ribosomal frameshift are currently under investigation in our laboratory.
Nevertheless, we report the discovery of pro-apoptotic Bax∆2 proteins in cerebellar neuron cells of young healthy individuals. The similar distribution pattern as 1 3 
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